CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...

Etherios, a division of Digi International, launched the Internet of Everything Kit by Etherios featuring the Qualcomm QSC6270-Turbo chipset, a development kit that includes all of the tools necessary ...

Private networks transitioning from connectivity platforms to intelligent automation infrastructure across manufacturing, healthcare, ports, and beyond.

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an ...